4 1 3 5 5 8 8 pentamethyltetralin 2 yl ethenyl benzoic acid, 4 1 5 6 7 8 tetrahydro 3 5 5 8 8 pentamethyl 2 naphtalenyl ethenyl benzoic acid, bexaroten
Used orally for the treatment of skin manifestations of cutaneous T-cell lymphoma (CTCL) in patients who are refractory to at least one prior systemic therapy. Also used topically ...